Results-oriented Executive Medical Director with 25 years of experience in clinical trials, focusing on oncology Phase I-III development. Proven expertise in problem-solving and patient safety, enhancing trial efficacy. Adept at building key opinion leader relationships and leveraging data-driven insights to consistently meet project milestones and contribute to advancements in medical science.
847-312-8520
Solid Tumors - Small and Non-small Lung Cancer, Breast, Sarcoma, 1, 2, Solid Tumors . Hema-onco Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), Multiple Myeloma/Plasma Cell Neoplasm, Polycythemia Vera. Metabolic & Cardio - Obesity, Type II Diabetes. Neurology - Epilepsy, Sleep Disorders. Psychiatry - Depression. Vaccines for Bacterial/Viral Disease Prevention. Rare Disorders. Device/Diagnostics: Cardiology, Oncology, Infectious, and Neurology.
Provides strategic leadership, organization, and training of the medical operations group. Supports assurance on growth of revenue and profitability through the provision of quality, medical services for the company’s internal executive management, project teams and clients. Provides medical services which include but is not limited to medical, clinical, and scientific advisory expertise, overall medical and safety oversight during project delivery lifecycle and medical contribution to proposal development and business development activities. Assures compliance with (1) standard operating procedures, (2) FDA and ROW agency guidelines, legislation, and procedures, (3) all applicable national and international regulations, and (4) Company and client project plans and expectations.